–
CNS Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.5
FY22:
−15.3
FY23:
−18.9
FY24:
−14.9
FY25:
−16.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.5
FY22:
−15.3
FY23:
−18.8
FY24:
−14.8
FY25:
−15.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.5
FY22:
−15.3
FY23:
−18.9
FY24:
−14.9
FY25:
−15.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.5
FY22:
−15.3
FY23:
−18.9
FY24:
−14.9
FY25:
−15.9
All amounts in millions USD